SignalRx Pharmaceuticals (United States)
- Research works
- 110 ▲ 25% vs 2013–17
- Citations
- 8.1k 73.6 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 29% world 28%
Not ranked overall: SignalRx Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does SignalRx Pharmaceuticals (United States) specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 5.6× the share of its output that it takes of world research.
- Molecular BiologySubfield · 24.5 works5.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at SignalRx Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Signaling, Immunity, Immune Response, Regulation, Cancer Therapy and NF-?B.
- Ras Signaling
- Calcium Signaling
- Nuclear Receptors
- Cell Signaling
- MAP Kinase
- BRAF gene
- Innate Immunity
- Tubulin Inhibitors
- Peptide Synthesis
- Cancer Progression
- Synthesis
- Drug Discovery
- Oncogenic Mutations
- STAT3
- Anticancer Agents
- Transcriptional Regulation
- NF-?B
- Regulation
- Immunity
- Cancer
- Inflammation
- Signaling
- Immune Response
- Cancer Therapy
- ubiquitination
- Tumor Microenvironment
- IL-6
- Medicinal Chemistry
- Apoptosis
- Heterocyclic Compounds
- Pattern Recognition Receptors
- Foldamers
- Signal Transduction
- Vascular Targeting Agents
- Reactive Oxygen Species
- Cell Migration
- Antimicrobial Activity
- Innate Antiviral Responses
- Toll-like Receptors
- Protein Kinases
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation23▲ 9.0×23 topics
- Cancer22▲ 15×22 topics
- Signaling12▲ 95×3 topics
- Immunity10▲ 28×5 topics
- Immune Response10▲ 14×8 topics
- Regulation10▲ 15×4 topics
- Cancer Therapy9▲ 13×12 topics
- NF-?B9▲ 268×1 topic
- ubiquitination9▲ 412×1 topic
- Transcriptional Regulation7▲ 27×6 topics
- Tumor Microenvironment7▲ 18×5 topics
- Anticancer Agents6▲ 22×5 topics
- IL-66▲ 164×1 topic
- STAT36▲ 164×1 topic
- Medicinal Chemistry6▲ 14×5 topics
- Oncogenic Mutations5▲ 98×2 topics
- Apoptosis5▲ 11×9 topics
- Drug Discovery5▲ 11×5 topics
- Heterocyclic Compounds4▲ 25×3 topics
- Synthesis4▲ 6.7×7 topics
- Pattern Recognition Receptors4▲ 25×2 topics
- Cancer Progression3▲ 12×4 topics
- Foldamers3▲ 35×1 topic
- Peptide Synthesis3▲ 35×1 topic
- Signal Transduction3▲ 12×4 topics
- Tubulin Inhibitors3▲ 54×1 topic
- Vascular Targeting Agents3▲ 54×1 topic
- Innate Immunity3▲ 7.0×5 topics
- Reactive Oxygen Species3▲ 4.9×4 topics
- BRAF gene3▲ 136×1 topic
- Cell Migration3▲ 28×2 topics
- MAP Kinase3▲ 136×1 topic
- Antimicrobial Activity2▲ 12×3 topics
- Cell Signaling2▲ 6.6×7 topics
- Innate Antiviral Responses2▲ 32×1 topic
- Nuclear Receptors2▲ 12×4 topics
- Toll-like Receptors2▲ 13×1 topic
- Calcium Signaling2▲ 16×2 topics
- Protein Kinases2▲ 73×1 topic
- Ras Signaling2▲ 73×1 topic
Which research topics does SignalRx Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: MicroRNA in disease regulation, Long-Term Effects of COVID-19, Respiratory Support and Mechanisms and Advanced Breast Cancer Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 MicroRNA in disease regulation Cancer Research 0 works
- 2 Long-Term Effects of COVID-19 Neurology 0 works
- 3 Respiratory Support and Mechanisms Pulmonary and Respiratory Medicine 0 works
- 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 5 Extracellular vesicles in disease Molecular Biology 0 works
- 6 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 7 Lung Cancer Research Studies Oncology 0 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 9 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
- 10 Wnt/β-catenin signaling in development and cancer Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has SignalRx Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 25% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Diego
- University of California San Diego
- San Diego State University
- Scripps Research Institute
- University of San Diego
- University of California San Diego Medical Center
- General Atomics (United States)
- Scripps Health
- Naval Medical Center San Diego
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.